Prenatal exposure to phthalates linked to higher risk of preterm birth and low birth weight

NorthX Bi­o­log­ics, a cell and gene ther­a­py man­u­fac­tur­ing and de­vel­op­ment out­fit based in Mat­fors, Swe­den, has ac­quired a fa­cil­i­ty from Val­ne­va. As part of the

Ca­li­di Bio­ther­a­peu­tics, a San Diego biotech work­ing on de­vel­op­ing al­lo­gene­ic cell de­liv­ery of on­colyt­ic virus­es, said Fri­day that in­vestors have com­mit­ted $25 mil­lion to a